Roche Receives Fda Approval For Expanded Use Of The Cintec Plus Cytology Test To Aid Clinicians In Preventing Cervical Cancer | Latest News RSS Feed

Roche Receives Fda Approval For Expanded Use Of The Cintec Plus Cytology Test To Aid Clinicians In Preventing Cervical Cancer - Latest News


Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

Next-generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly 100 percent preventable with proper screening, vaccination and treatment ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Roche: FDA Approves Expanded Use Of CINtec PLUS Cytology Test To Help To Prevent Cervical Cancer

(RTTNews) - Swiss drug maker Roche Group (RHHBY) announced Wednesday that the U.S. Food and Drug Administration has approved the expanded use of CINtec PLUS Cytology test to aid clinicians in ... read more

Press Release: Roche receives FDA approval for -2-

are positive for high-risk types of human papillomavirus (HPV). read more

Looking for other news?


Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us